Patents by Inventor Pascal Bonnarme

Pascal Bonnarme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220295840
    Abstract: A modulated protein composition is described with improved flavor properties over a vegetable protein. Methods of making a modulated protein composition including the use of a volatile modulating yeast culture to ferment a vegetable protein to produce the modulated protein composition are described. Also disclosed are a fermented vegetable composition made from a modulated protein composition, and ingredients and foods including a fermented vegetable composition or a modulated protein composition.
    Type: Application
    Filed: July 31, 2019
    Publication date: September 22, 2022
    Applicants: SODIMA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), INSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT
    Inventors: Sébastien Fraud, Cynthia El Youssef, Pascal Bonnarme, Sophie Landaud-Liautaud, Sandra Helinck
  • Patent number: 9051562
    Abstract: The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: June 9, 2015
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), INRA (Institut National de la Recherche Agronomique), UNIVERSITE PARIS SUD-PARIS XI
    Inventors: David Machover, Pascal Bonnarme
  • Publication number: 20140140978
    Abstract: The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.
    Type: Application
    Filed: June 15, 2012
    Publication date: May 22, 2014
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), UNIVERSITE PARIS SUD-PARIS XI, INRA (Institut National de la Recherche Agronomique)
    Inventors: David Machover, Pascal Bonnarme